OXYGENTA PHARMACEUTICAL
Back to Income Statement
|
OXYGENTA PHARMACEUTICAL Last 5 Year Revenue History
[Standalone]
Mar2024 | Mar2023 | Mar2022 | Mar2021 | Mar2020 | |
---|---|---|---|---|---|
Net Sales | ₹40 Cr | ₹31 Cr | ₹61 Cr | ₹52 Cr | ₹14 Cr |
What is the latest Revenue of OXYGENTA PHARMACEUTICAL ?
Year | Revenue |
---|---|
Mar2024 | ₹40 Cr |
Mar2023 | ₹31 Cr |
Mar2022 | ₹61 Cr |
Mar2021 | ₹52 Cr |
Mar2020 | ₹14 Cr |
How is Revenue of OXYGENTA PHARMACEUTICAL Trending?
Years | Revenue | % Change | |
---|---|---|---|
Mar2024 | ₹40 Cr | 27.93 | |
Mar2023 | ₹31 Cr | -48.80 | |
Mar2022 | ₹61 Cr | 16.33 | |
Mar2021 | ₹52 Cr | 279.32 | |
Mar2020 | ₹14 Cr | - |
Compare Revenue of peers of OXYGENTA PHARMACEUTICAL
Peers & Returns | Market Capitalization | 1 Week | 1 Month | 1 Year | ||
OXYGENTA PHARMACEUTICAL | ₹251.6 Cr | -4.2% | -7.9% | 19.3% | Stock Analytics | |
SUN PHARMACEUTICAL INDUSTRIES | ₹382,682.0 Cr | -2% | 2% | -16.2% | Stock Analytics | |
DIVIS LABORATORIES | ₹150,985.0 Cr | -5% | -6.6% | 5.9% | Stock Analytics | |
TORRENT PHARMACEUTICALS | ₹121,862.0 Cr | -0.4% | 0.5% | 5.2% | Stock Analytics | |
CIPLA | ₹121,294.0 Cr | -2.4% | -5.4% | -8.2% | Stock Analytics | |
DR REDDYS LABORATORIES | ₹102,132.0 Cr | -5.8% | -4.4% | -8.4% | Stock Analytics |
OXYGENTA PHARMACEUTICAL Share Price vs Sensex
Share Price Returns(%) | 1 Week | 1 Month | 1 Year |
OXYGENTA PHARMACEUTICAL | -4.2% |
-7.9% |
19.3% |
SENSEX | -2.2% |
0.6% |
-5.8% |
You may also like the below Video Courses